Cargando…
Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood
BACKGROUND: Since recombinant human growth hormone (rhGH) became available in 1985, the spectrum of indications has broadened and the number of treated patients increased. However, long-term health-related quality of life (HRQoL) after childhood rhGH treatment has rarely been documented. We assessed...
Autores principales: | Sommer, Grit, Gianinazzi, Micol E., Kuonen, Rahel, Bohlius, Julia, l’Allemand, Dagmar, Hauschild, Michael, Mullis, Primus-Eugen, Kuehni, Claudia E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608786/ https://www.ncbi.nlm.nih.gov/pubmed/26474398 http://dx.doi.org/10.1371/journal.pone.0140944 |
Ejemplares similares
-
Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study
por: Weiss, Annette, et al.
Publicado: (2017) -
Intra-Rater and Inter-Rater Reliability of a Medical Record Abstraction Study on Transition of Care after Childhood Cancer
por: Gianinazzi, Micòl E., et al.
Publicado: (2015) -
Genetics of Isolated Growth Hormone Deficiency
por: E. Mullis, Primus
Publicado: (2010) -
No evidence of response bias in a population-based childhood cancer survivor questionnaire survey — Results from the Swiss Childhood Cancer Survivor Study
por: Rueegg, Corina S., et al.
Publicado: (2017) -
Who Knows? Information Received, and Knowledge about, Cancer, Treatment and Late Effects in a National Cohort of Long-Term Childhood, Adolescent and Young Adult Cancer Survivors
por: Gianinazzi, Micol E., et al.
Publicado: (2022)